2022 Annual Conference

Dr. Rhonda Yantiss is a Professor of Pathology and Laboratory Medicine and Chief of Gastrointestinal Pathology at Weill Cornell Medical College. She served as President for the Rodger C. Haggitt Gastrointestinal Pathology Society and Arthur Purdy Stout Society of Surgical Pathologists, and chairs the Education Committee of the United States and Canadian Academy of Pathology. Dr. Yantiss has received several awards, including the USCAP F. K. Mostofi Distinguished Service Award, Arthur Purdy Stout Society of Pathology Annual Prize, and Jack Yardley Investigator Award of the Rodger C. Haggitt Gastrointestinal Pathology Society. She has published more than 150 original articles, numerous book chapters, and textbooks. She serves on the editorial boards of Human Pathology, Seminars in Diagnostic Pathology, and The American Journal of Surgical Pathology, is Deputy Editor-in-Chief of Archives of Pathology and Laboratory Medicine, and a Senior Associate Editor of Modern Pathology.

Dr. Raphael has practiced Pathology in Academic and Community settings for 32 years. His career was always centered around education which led naturally to positions where the assessment of physician attributes and competence were important. He has been a Residency Program Director and RCPSC examiner as well as a CPSO assessor. For the last 9 years he has been Chief of Pathology at North York General Hospital and for the last 2 years has been Chair of MAC in the same institution.

Many years of clinical service in gynecologic and obstetric pathology at multiple large medical centers in the US and Canada.

Dr. Andrew Evans is the Medical Director of Laboratory Medicine at Mackenzie Health (MH), a large community hospital in North Toronto that has transitioned to complete reporting by digital pathology. Prior to moving to MH in 2020, he was the Director of Digital Pathology at University Health Network (UHN) from the inception of the program in 2004.

Over the last 10 years, Dr. Evans has been extensively involved in the development of guidelines and best practice documents for digital pathology with the College of American Pathologists (CAP). He chaired the expert panel for the recently updated CAP WSI Validation Guideline. He chaired the CAP Digital and Computational Pathology Committee from 2016-2021 and is currently a member of the CAP Artificial Intelligence Committee. His work in digital pathology was recognized with Meritorious Service Lifetime Achievement Award from The CAP in September, 2021.

Claire Holloway MD PhD FRCSC is a breast surgical oncologist formerly of the Odette Cancer Centre at Sunnybrook Hospital, Claire is also Associate Professor, Department of Surgery at the University of Toronto. She has served on the advisory committees for a number of provincial and national public institutions and not-for-profit organizations including the Canadian Breast Cancer Research Alliance, the Canadian Breast Cancer Foundation and Cancer Care Ontario.

She is CCO's inaugural Provincial Clinical Lead, Disease Pathway Management supporting the evolution and execution of the Disease Pathway Management (DPM) approach, which focuses on the integration of care across the care continuum care from a disease-specific perspective. She also led CCO's Diagnostic Assessment Program until its discontinuation in 2018

Michael Pollanen is Professor and Vice-Chair (Innovation) of Laboratory Medicine and Pathobiology at the University of Toronto and the Chief Forensic Pathologist for Ontario Canada. Professor Pollanen's main academic focus the application of forensic medicine to Global Health by training forensic pathologists and strengthening forensic capacity in the Global South. His current research interest is nodding Syndrome in Uganda. He has published over 100 papers in peer-reviewed journals. Professor Pollanen is a member of the forensic advisory board of the International Committee of the Red Cross and is a Past President of the International Association of Forensic Science (2015-17). His professional duties include supervising and directing the Ontario Forensic Pathology Service (9000 autopsies/year), conducting autopsy (>4500 autopsies conducted to date) testifying in court (>250 court testimonies to date), and directing academic activities in forensic pathology at the University of Toronto

Stephen M. Smith is a board-certified surgical pathologist specializing in Endocrine, Head & Neck and Dermatopathology. He presently practices in the Department of Laboratory Medicine and Pathobiology at Toronto General Hospital (University Health Network) and is an Assistant Professor of Laboratory Medicine and Pathobiology at the University of Toronto. He is fellowship-trained in Endocrine, Head & Neck Pathology (Yale University School of Medicine) and Dermatopathology (The Ohio State University Wexner Medical Center). His research interests include social issues in medicine, clinicopathologic correlates in endocrine and dermatopathology, and identification of novel diagnostic markers and methods in surgical pathology. Dr. Smith is a diplomate of the American Board of Pathology (AP/CP, DermPath).

Dr. Selvarajah obtained her Ph.D. at the University of Toronto, before heading to Boston for a post-doctoral fellowship with the Dana-Farber Cancer Institute and an ABMGG accredited clinical cytogenetics fellowship with the Harvard Medical School Genetics Training Program. Upon returning to Toronto, she completed a second laboratory fellowship in Clinical Molecular Genetics at McMaster University while working as a Cytogeneticist at Trillium Health Partners. She is currently a clinical molecular geneticist in the Division of Clinical Laboratory Genetics at the University Health Network. Her academic interests are focused on genitourinary cancer genomics and biomarker development through the application of high throughput technologies. She is an Assistant Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and has been actively involved in teaching residents and fellows in the area of cancer genetics.

Dr. Sheffield is an anatomic and molecular pathologist. He is currently serving as the Medical Director of Immunohistochemistry and Molecular Pathology and the Physician Lead of Research for the William Osler Health System in Canada. Dr. Sheffield focuses on the delivery of personalized medicine and precision oncology and making molecular testing available to community cancer patients in Canada.

Dr. Berardi is an Associate Professor at the University of Ottawa and staff Hematopathologist at the Ottawa Hospital/Eastern Ontario Regional Laboratory Association. His clinical practice focusses primarily on the diagnosis and monitoring of Leukemia and Lymphoma and he is interested in the ongoing development of molecular diagnostic tools, precision medicine and targeted therapies.

Dr. Downes graduated from the Royal College of Surgeons in Ireland medical school and undertook training in surgery followed by a research fellowship in prostate cancer at University College Dublin. She trained in Anatomic Pathology in Dublin, Ireland and then completed a clinical fellowship in genitourinary pathology at UHN, Toronto. Dr Downes is lead GU pathologist, Division Head of Anatomic Pathology and the inaugural Research Director for the Precision Diagnostics and Therapeutics Program at Sunnybrook Health Sciences Centre. She is an Associate Professor in Laboratory Medicine and Pathobiology at the University of Toronto. Dr Downes is actively engaged in teaching and is a committee member of multiple organizations that facilitate knowledge transfer and disseminate best practice recommendations to the pathology and clinical community (CAP-ACP, OMPRN, CNUP and ISUP). Her research interests focus on prognostic and predictive biomarkers in prostate and bladder cancers.

Dr. Feilotter is a Professor in the Department of Pathology and Molecular Medicine at Queen's University, where she maintains an active program dedicated to the assessment of methods for biomarker validation and to the transfer of clinically actionable molecular assays to the clinical setting. Her roles as Service Chief of Kingston Health Sciences Center's Laboratory Genetics and Senior Scientist for Molecular Diagnostics and Translational Research within the Canadian Clinical Trials Group allow her to focus on methods to bridge the gap between research and clinical application of biomarker findings. She holds appointments at the Ontario Institute for Cancer Research where she acts as Director of the Ontario Molecular Pathology Research Network within the Adaptive Oncology program and Lead for Clinical Implementation within the Clinical Translation program. She currently serves as the Chair of the Molecular Oncology Testing Advisory Committee to Cancer Care Ontario (OH/CCO).

T. (Dorien) Ruijs is a General Pathologist and since 2021 the Clinical Project Coordinator with the Ontario Regional Blood Coordinating Network (ORBCoN). She has over 20 years' experience as Transfusion Laboratory Director at William Osler Health System and is the Medical Laboratory Director at Headwaters Health Care Centr